The two major oncogenic mutations linked to the progression of HCC were the Wingless‐related integration site (Wnt)/beta‐catenin and JAK/STAT pathways, which were altered in 62.5% and 45.5% of patients, respectively.36 The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.